Valion Bio (VBIO) Q2 2024 Earnings Report

174 Followers

VBIO Q2 2024 EPS Results

Actual EPS-$136.00

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$2975.00

Actual Revenue$140.00K

Expected Revenue―

Beat/Miss―

YoY Revenue Growth-13.04%

QuarterQ2 2024

Date08/14/2024

TimeAfter Close

Conference CallWednesday, August 14, 2024

VBIO Upcoming Earnings

Valion Bio's next earnings date is estimated for November 13, 2026, based on past reporting schedules.

VBIO Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 13, 2026	2026 (Q3)	- / -	-1.966	―
Aug 17, 2026	2026 (Q2)	- / -52.54	-54.778	4.09% (+2.24)
May 14, 2026	2026 (Q1)	- / -53.77	-62.964	14.60% (+9.20)
Mar 25, 2026	2025 (Q4)	- / -	-2.652	―
Nov 14, 2025	2025 (Q3)	- / -49.14	-97.75	49.73% (+48.61)
Aug 14, 2025	2025 (Q2)	- / -54.78	-136	59.72% (+81.22)
May 15, 2025	2025 (Q1)	- / -62.96	-429.25	85.33% (+366.29)
Mar 21, 2025	2024 (Q4)	- / -66.30	3859	-101.72% (-3925.30)
Nov 15, 2024	2024 (Q3)	- / -97.75	-629	84.46% (+531.25)
Aug 14, 2024	2024 (Q2)	- / -136.00	-2975	95.43% (+2839.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed